vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and KAMADA LTD (KMDA). Click either name above to swap in a different company.

KAMADA LTD is the larger business by last-quarter revenue ($47.0M vs $39.9M, roughly 1.2× HARTE HANKS INC). KAMADA LTD runs the higher net margin — 11.3% vs 5.5%, a 5.7% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs -15.4%). Over the past eight quarters, KAMADA LTD's revenue compounded faster (12.0% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

HHS vs KMDA — Head-to-Head

Bigger by revenue
KMDA
KMDA
1.2× larger
KMDA
$47.0M
$39.9M
HHS
Growing faster (revenue YoY)
KMDA
KMDA
+28.1% gap
KMDA
12.6%
-15.4%
HHS
Higher net margin
KMDA
KMDA
5.7% more per $
KMDA
11.3%
5.5%
HHS
Faster 2-yr revenue CAGR
KMDA
KMDA
Annualised
KMDA
12.0%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HHS
HHS
KMDA
KMDA
Revenue
$39.9M
$47.0M
Net Profit
$2.2M
$5.3M
Gross Margin
42.0%
Operating Margin
-0.3%
16.6%
Net Margin
5.5%
11.3%
Revenue YoY
-15.4%
12.6%
Net Profit YoY
37.1%
EPS (diluted)
$0.30
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
KMDA
KMDA
Q4 25
$39.9M
Q3 25
$39.5M
$47.0M
Q2 25
$38.6M
$44.8M
Q1 25
$41.6M
$44.0M
Q4 24
$47.1M
Q3 24
$47.6M
$41.7M
Q2 24
$45.0M
$42.5M
Q1 24
$45.4M
$37.7M
Net Profit
HHS
HHS
KMDA
KMDA
Q4 25
$2.2M
Q3 25
$-2.3M
$5.3M
Q2 25
$-335.0K
$7.4M
Q1 25
$-392.0K
$4.0M
Q4 24
Q3 24
$142.0K
$3.9M
Q2 24
$-27.8M
$4.4M
Q1 24
$-171.0K
$2.4M
Gross Margin
HHS
HHS
KMDA
KMDA
Q4 25
Q3 25
42.0%
Q2 25
42.3%
Q1 25
47.1%
Q4 24
Q3 24
41.3%
Q2 24
44.6%
Q1 24
44.4%
Operating Margin
HHS
HHS
KMDA
KMDA
Q4 25
-0.3%
Q3 25
1.3%
16.6%
Q2 25
0.1%
15.8%
Q1 25
-0.1%
17.7%
Q4 24
-3.3%
Q3 24
4.0%
12.7%
Q2 24
3.0%
13.3%
Q1 24
0.8%
10.7%
Net Margin
HHS
HHS
KMDA
KMDA
Q4 25
5.5%
Q3 25
-5.8%
11.3%
Q2 25
-0.9%
16.5%
Q1 25
-0.9%
9.0%
Q4 24
Q3 24
0.3%
9.3%
Q2 24
-61.8%
10.4%
Q1 24
-0.4%
6.3%
EPS (diluted)
HHS
HHS
KMDA
KMDA
Q4 25
$0.30
Q3 25
$-0.31
$0.09
Q2 25
$-0.05
$0.13
Q1 25
$-0.05
$0.07
Q4 24
$-0.31
Q3 24
$0.02
$0.07
Q2 24
$-3.84
$0.08
Q1 24
$-0.02
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
KMDA
KMDA
Cash + ST InvestmentsLiquidity on hand
$5.6M
$72.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$265.2M
Total Assets
$91.8M
$377.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
KMDA
KMDA
Q4 25
$5.6M
Q3 25
$6.5M
$72.0M
Q2 25
$4.8M
$66.0M
Q1 25
$9.0M
$76.3M
Q4 24
$9.8M
Q3 24
$5.9M
$72.0M
Q2 24
$11.0M
$56.5M
Q1 24
$11.5M
$48.2M
Stockholders' Equity
HHS
HHS
KMDA
KMDA
Q4 25
$20.5M
Q3 25
$19.9M
$265.2M
Q2 25
$22.2M
$260.0M
Q1 25
$21.4M
$252.0M
Q4 24
$21.7M
Q3 24
$21.0M
$255.3M
Q2 24
$20.6M
$251.2M
Q1 24
$20.0M
$251.2M
Total Assets
HHS
HHS
KMDA
KMDA
Q4 25
$91.8M
Q3 25
$92.7M
$377.2M
Q2 25
$95.0M
$368.2M
Q1 25
$100.6M
$375.1M
Q4 24
$101.8M
Q3 24
$108.1M
$351.2M
Q2 24
$109.7M
$351.0M
Q1 24
$113.4M
$343.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
KMDA
KMDA
Operating Cash FlowLast quarter
$737.0K
$10.4M
Free Cash FlowOCF − Capex
$-686.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
0.33×
1.97×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
KMDA
KMDA
Q4 25
$737.0K
Q3 25
$3.2M
$10.4M
Q2 25
$-4.8M
$8.0M
Q1 25
$-818.0K
$-513.0K
Q4 24
$4.0M
Q3 24
$-2.9M
$22.2M
Q2 24
$1.6M
$14.0M
Q1 24
$-5.7M
$1.0M
Free Cash Flow
HHS
HHS
KMDA
KMDA
Q4 25
$-686.0K
Q3 25
$2.2M
Q2 25
$-5.1M
Q1 25
$-923.0K
Q4 24
$3.4M
Q3 24
$-4.9M
Q2 24
$926.0K
Q1 24
$-6.2M
FCF Margin
HHS
HHS
KMDA
KMDA
Q4 25
-1.7%
Q3 25
5.5%
Q2 25
-13.1%
Q1 25
-2.2%
Q4 24
7.3%
Q3 24
-10.2%
Q2 24
2.1%
Q1 24
-13.7%
Capex Intensity
HHS
HHS
KMDA
KMDA
Q4 25
3.6%
Q3 25
2.5%
Q2 25
0.6%
Q1 25
0.3%
Q4 24
1.3%
Q3 24
4.0%
Q2 24
1.5%
Q1 24
1.2%
Cash Conversion
HHS
HHS
KMDA
KMDA
Q4 25
0.33×
Q3 25
1.97×
Q2 25
1.09×
Q1 25
-0.13×
Q4 24
Q3 24
-20.76×
5.75×
Q2 24
3.15×
Q1 24
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

KMDA
KMDA

Segment breakdown not available.

Related Comparisons